Back
FibroGen Vs. Denali Therapeutics Industry Stock Comparison
Buy
52
FGEN
FibroGen
Last Price:
$0.55
Seasonality Move:
1.68%
Sell
11
DNLI
Denali Therapeutics
Last Price:
$18.74
Seasonality Move:
-5.23%
Sell
11
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy, Sell or Hold?
-
The current Denali Therapeutics [DNLI] share price is $18.74. The Score for DNLI is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
DNLI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
FGEN Stock Price Chart
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $18.74Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
FGEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 56.79 | Buy |
Chaikin Money Flow: | -124939 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.35 - 0.59) | Buy |
Bollinger Bands (100): | (0.32 - 0.48) | Buy |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.24 | Sell |
Relative Strength Index (14 RSI): | 33.72 | Sell |
Chaikin Money Flow: | -648364 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.93 - 23.39) | Sell |
Bollinger Bands (100): | (22.5 - 28.78) | Sell |
FGEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.6 | Sell |
20-day SMA: | 0.5 | Buy |
50-day SMA: | 0.42 | Buy |
200-day SMA: | 0.75 | Sell |
8-day EMA: | 0.58 | Sell |
20-day EMA: | 0.53 | Buy |
50-day EMA: | 0.46 | Buy |
200-day EMA: | 1.01 | Sell |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.22 | Sell |
20-day SMA: | 20.99 | Sell |
50-day SMA: | 24.05 | Sell |
200-day SMA: | 23.05 | Sell |
8-day EMA: | 19.97 | Sell |
20-day EMA: | 21.08 | Sell |
50-day EMA: | 23.06 | Sell |
200-day EMA: | 23.63 | Sell |
FibroGen Earnings Growth & FGEN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.18 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.79 per share.
FibroGen Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |